The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridium difficile infection and other potential indications: joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines

Benjamin H. Mullish; Mohammed Nabil Quraishi; Jonathan P. Segal; Victoria L. McCune; Melissa Baxter; Gemma L. Marsden; David Moore; Alaric Colville; Neeraj Bhala; Tariq H. Iqbal; Christopher Settle; Graziella Kontkowski; Ailsa L. Hart; Peter Hawkey; Horace RT Williams; Simon D. Goldenberg

doi:10.1016/j.jhin.2018.07.037

The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridium difficile infection and other potential indications: joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines

Benjamin H. Mullish, Mohammed Nabil Quraishi, Jonathan P. Segal, Victoria L. McCune, Melissa Baxter, Gemma L. Marsden, David Moore, Alaric Colville, Neeraj Bhala, Tariq H. Iqbal, Christopher Settle, Graziella Kontkowski, Ailsa L. Hart, Peter Hawkey, Horace RT Williams, Simon D. Goldenberg^*

^*Corresponding author for this work

Research output: Contribution to journal › Short survey › peer-review

45 Citations (Scopus)

Original language	English
Pages (from-to)	S1-S31
Journal	Journal of Hospital Infection
Volume	100
DOIs	https://doi.org/10.1016/j.jhin.2018.07.037
Publication status	Published - Sept 2018

Bibliographical note

Funding Information:
There was no external funding for this work. BHM is the recipient of a Medical Research Council (MRC) Clinical Research Training Fellowship (grant reference: MR/R000875/1). BHM and HRTW receive support from the National Institute for Health Research (NIHR) Imperial Biomedical Research Centre (BRC) based at Imperial College Healthcare NHS Trust and Imperial College London.

Keywords

Clostridium difficile
faecal transplant
inflammatory bowel disease
microbiota

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.jhin.2018.07.037

Cite this

Mullish, B. H., Quraishi, M. N., Segal, J. P., McCune, V. L., Baxter, M., Marsden, G. L., Moore, D., Colville, A., Bhala, N., Iqbal, T. H., Settle, C., Kontkowski, G., Hart, A. L., Hawkey, P., Williams, H. RT., & Goldenberg, S. D. (2018). The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridium difficile infection and other potential indications: joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines. Journal of Hospital Infection, 100, S1-S31. https://doi.org/10.1016/j.jhin.2018.07.037

Mullish, Benjamin H. ; Quraishi, Mohammed Nabil ; Segal, Jonathan P. et al. / The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridium difficile infection and other potential indications : joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines. In: Journal of Hospital Infection. 2018 ; Vol. 100. pp. S1-S31.

@article{a2f0193e28434429b0d20e1d906cbd48,

title = "The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridium difficile infection and other potential indications: joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines",

keywords = "Clostridium difficile, faecal transplant, inflammatory bowel disease, microbiota",

author = "Mullish, {Benjamin H.} and Quraishi, {Mohammed Nabil} and Segal, {Jonathan P.} and McCune, {Victoria L.} and Melissa Baxter and Marsden, {Gemma L.} and David Moore and Alaric Colville and Neeraj Bhala and Iqbal, {Tariq H.} and Christopher Settle and Graziella Kontkowski and Hart, {Ailsa L.} and Peter Hawkey and Williams, {Horace RT} and Goldenberg, {Simon D.}",

note = "Funding Information: There was no external funding for this work. BHM is the recipient of a Medical Research Council (MRC) Clinical Research Training Fellowship (grant reference: MR/R000875/1). BHM and HRTW receive support from the National Institute for Health Research (NIHR) Imperial Biomedical Research Centre (BRC) based at Imperial College Healthcare NHS Trust and Imperial College London.",

year = "2018",

month = sep,

doi = "10.1016/j.jhin.2018.07.037",

language = "English",

volume = "100",

pages = "S1--S31",

journal = "Journal of Hospital Infection",

issn = "0195-6701",

publisher = "W.B. Saunders Ltd",

}

Mullish, BH, Quraishi, MN, Segal, JP, McCune, VL, Baxter, M, Marsden, GL, Moore, D, Colville, A, Bhala, N, Iqbal, TH, Settle, C, Kontkowski, G, Hart, AL, Hawkey, P, Williams, HRT & Goldenberg, SD 2018, 'The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridium difficile infection and other potential indications: joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines', Journal of Hospital Infection, vol. 100, pp. S1-S31. https://doi.org/10.1016/j.jhin.2018.07.037

The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridium difficile infection and other potential indications: joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines. / Mullish, Benjamin H.; Quraishi, Mohammed Nabil; Segal, Jonathan P. et al.
In: Journal of Hospital Infection, Vol. 100, 09.2018, p. S1-S31.

Research output: Contribution to journal › Short survey › peer-review

TY - JOUR

T1 - The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridium difficile infection and other potential indications

T2 - joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines

AU - Mullish, Benjamin H.

AU - Quraishi, Mohammed Nabil

AU - Segal, Jonathan P.

AU - McCune, Victoria L.

AU - Baxter, Melissa

AU - Marsden, Gemma L.

AU - Moore, David

AU - Colville, Alaric

AU - Bhala, Neeraj

AU - Iqbal, Tariq H.

AU - Settle, Christopher

AU - Kontkowski, Graziella

AU - Hart, Ailsa L.

AU - Hawkey, Peter

AU - Williams, Horace RT

AU - Goldenberg, Simon D.

N1 - Funding Information: There was no external funding for this work. BHM is the recipient of a Medical Research Council (MRC) Clinical Research Training Fellowship (grant reference: MR/R000875/1). BHM and HRTW receive support from the National Institute for Health Research (NIHR) Imperial Biomedical Research Centre (BRC) based at Imperial College Healthcare NHS Trust and Imperial College London.

PY - 2018/9

Y1 - 2018/9

KW - Clostridium difficile

KW - faecal transplant

KW - inflammatory bowel disease

KW - microbiota

UR - http://www.scopus.com/inward/record.url?scp=85051656077&partnerID=8YFLogxK

U2 - 10.1016/j.jhin.2018.07.037

DO - 10.1016/j.jhin.2018.07.037

M3 - Short survey

C2 - 30173851

AN - SCOPUS:85051656077

SN - 0195-6701

VL - 100

SP - S1-S31

JO - Journal of Hospital Infection

JF - Journal of Hospital Infection

ER -

Mullish BH, Quraishi MN, Segal JP, McCune VL, Baxter M, Marsden GL et al. The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridium difficile infection and other potential indications: joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines. Journal of Hospital Infection. 2018 Sept;100:S1-S31. doi: 10.1016/j.jhin.2018.07.037

The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridium difficile infection and other potential indications: joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines

Bibliographical note

Keywords

UN SDGs

Access to Document

Other files and links

Cite this